New molecular challenges in CRC
BRAF mutations: What are the treatment options?
Date
09 Oct 2016Session
New molecular challenges in CRCPresenters
Fotios LoupakisAuthors
F. LoupakisAuthor affiliations
- Department Of Clinical And Experimental Oncology, Istituto Oncologico Veneto IOV IRCCS, 57100 - Livorno/IT
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Introduction
Presenter: Per Pfeiffer
Session: New molecular challenges in CRC
Resources:
Slides
New classification of CRC: “Gone molecular”?
Presenter: Daniela Aust
Session: New molecular challenges in CRC
Resources:
Slides
Liquid biopsies: Ever closer to daily practice?
Presenter: Pierre Laurent-Puig
Session: New molecular challenges in CRC
Resources:
Slides
Immunotherapy in mCRC: MSI and beyond
Presenter: Neil Segal
Session: New molecular challenges in CRC
Resources:
Slides
Conclusions and clinical perspectives
Presenter: Sabine Tejpar
Session: New molecular challenges in CRC
Resources:
Slides
Patients with rare molecular alterations: Do they need a precision approach?
Presenter: Salvatore Siena
Session: New molecular challenges in CRC
Resources:
Slides